Health Innovation Network Health Innovation Podcast

A small, portable device that can zap away excruciating headaches is proving to be a life-saver for thousands of sufferers.
GammaCore is supported through the NHS MedTech Funding Mandate, increasing availability for those diagnosed with cluster headaches.
In this podcast we hear from sufferer Andreea Duca who says her life was saved by GammaCore – and from a neurologist who is the UK’s biggest prescriber of the device, Dr Nick Silver of The Walton Centre NHS Foundation Trust. 
They are talking to podcast host Dr Phil Jennings, chief executive of the Innovation Agency and the lead for the AHSN Network on the Accelerated Access Collaborative Rapid Uptake Products programme and MedTech Funding Mandate.
Useful links: 
The Walton Centre NHS Foundation Trust comprehensive guide to migraine: www.bit.ly/migrainebooklet 

The Migraine Trust www.migrainetrust.org 

Migraine Action http://www.migraine.org.uk 

The Brain Charity www.thebraincharity.org.uk

Organisation for the Understanding of Cluster Headache (OUCH UK) www.ouchuk.org 

The British Association for the Study of Headache www.bash.org.uk 

In this episode, our host Dr Hasan Chowhan meets with fellow GP Dr Simon Dunn to discuss the increased use of remote health technology, in particular the successful implementation of Covid Oximetry@home in his Clinical Commissioning Group (Kent & Medway).
Hasan also investigates other remote health technology from Whzan, Tytocare and HCI Digital, looking at how we can offer solutions that work for everyone.

More than 100 hospital trusts in England have adopted a device that improves the experience of patients – and saves money for the NHS.

SecuraCath secures central venous catheters without requiring sutures or adhesives, improving patient safety and experience.

It’s been spread by the country’s 15 AHSNs through the Accelerated Access Collaborative’s Innovation and Technology Payment programme and is now supported through the Med Tech Funding Mandate.

It was first used in the UK by the Clatterbridge Cancer Centre NHS Foundation Trust, after being taken up by Clinical Interventions Lead Nurse Carol McCormick.

In this episode, Carol talks to Dr Phil Jennings as part of a series of podcasts about innovations being fast-tracked into use in the NHS.

To contact Carol with any questions about introducing SecurAcath, she can be emailed at: [email protected].

Read more here on the AHSN Network website:
https://www.ahsnnetwork.com/more-than-100-nhs-trusts-now-using-ahsn-supported-medical-device-to-secure-catheters-more-effectively

Find out more about the AAC Rapid Uptake Products programme here:

https://www.england.nhs.uk/aac/what-we-do/what-innovations-do-we-support/rapid-uptake-products/

The third episode in a short series focusing on the AHSN Network at #HETT21. Our roving reporter, Nigel Thompson, interviews Neville Young, Director of Enterprise and Innovation at Yorkshire & Humber AHSN and Darren Crombie from Bridgit Care, one of the innovators hosted in the AHSN Network innovator zone. They discuss how AHSNs support innovators.

The second episode in a short series focusing on the AHSN Network at #HETT21. Our roving reporter, Nigel Thompson, interviews Tim Robinson, Commercial Director from East Midlands AHSN and Pamela Penn from Spirit Digital, one of the innovators hosted in the AHSN Network innovator zone. They discuss how AHSNs support innovators.

The first episode in a short series focusing on the AHSN Network at #HETT21 and the associated themes. Featuring AHSN-supported innovators and AHSN experts on their take on this year’s show.

It’s suspected that 30 per cent of 5.4 million patients currently diagnosed with asthma in the UK have been misdiagnosed. 

The NHS spends £1.1 billion on asthma treatment and management annually, with 90 per cent of this cost going directly on medication, including the prescription of steroid inhalers. 
In this episode, we hear about a programme to improve the diagnosis and management of asthma within primary care, involving the spread of a breathing test called FeNO. 

This test looks at how much nitric oxide – a type of gas – is in your breath when you breath out and can show the level of inflammation in the lungs. The test is easy to do, you simply breath into a tube - and it takes less than a minute. FeNO testing is a key piece in the diagnostic jigsaw and can help improve care for people with asthma.

Host Dr Phil Jennings talks to severe asthma sufferer Emma Thompson and Carol Stonham, a Senior Nurse Practitioner and the Executive Chair of the Primary Care Respiratory Society.

Carol is a member of the national FeNO programme, one of the Rapid Uptake Product programmes, run by the NHS England Accelerated Access Collaborative with the support of the AHSN Network.

Find out more about the Rapid Uptake Products (RUP) programme, designed to support stronger adoption and spread of proven innovations.

Professionals can access a wide range of support tools for implementing FeNO testing, on the Wessex AHSN website.

Around 1,400 people each year die from a severe asthma attack; and asthma deaths are 50 per cent more likely in poorest areas compared with the richest.

Now, people with severe asthma are being offered a newer type of treatment alongside their usual asthma medicines. These are known as monoclonal antibodies, also referred to as biologics.

Biologics are a game changer for people whose lives have been blighted by asthma, helping them to live normal lives – and reducing the risk of a fatal attack. 

We hear from Joanne Beecroft who has been taking biologics; and from asthma doctor Dr Hitasha Rupani who is leading a national programme to increase uptake of the medicines, run by the NHS Accelerated Access Collaborative with the support of the AHSN Network.

The national programme, known as the Rapid Uptake Products programme, focuses on a number of products which have been proved to significantly improve care and reduce NHS costs.
Our guests talk to Dr Phil Jennings, AHSN Network Lead for the Rapid Uptake Products.
Find out more about the AAC Rapid Uptake Products programme here.

In this episode our host Dr Hasan Chowhan delves into the NHS Innovation Accelerator and Digital Health.London Accelerator - two programmes run by the AHSN Network to help fast track health innovators to meet the challenges facing the NHS and social care system today.

What do they offer innovators? Which one should you apply for? Do they really help? Hasan finds out by questioning one of the AHSN Network's Commercial Directors, Anna King (from the Health Innovation Network - south London AHSN.)

Hasan also catches up with super successful Accelerator alumni: Tom Whicher from Dr Doctor; Charlotte Wood from Oxehealth; and Carly Edwards from S12 Solutions; who have some interesting insights and inspiring stories.

One of the causes of heart attack and stroke is a genetic condition called Familial Hypercholesterolaemia (FH), which creates an abnormal level of cholesterol in the blood.
A 34-year old woman in Carlisle, Ciara Wannop, didn’t know she had the condition until she had a heart attack while 26 weeks’ pregnant. She feels lucky to have had an early warning of a potentially life-limiting condition.
In this podcast, she is joined by Dr Youssef Beaini who is the clinical lead of a national programme from the NHS Accelerated Access Collaborative, to help reduce heart disease.
Called the Rapid Uptake Products programme, which is delivered by the AHSN Network, it focuses on a number of products which have been proved to significantly improve care and reduce NHS costs.
Our guests talk to Dr Phil Jennings, AHSN Network Lead for the Rapid Uptake Products.